Visceral Hypersensitivity: How to Know If You Have It (And What to Do About It)
If you have heard 'visceral hypersensitivity' in a podcast, a study, or somewhere on the IBS internet, and you are now wondering whether it actually applies to you, this is the plain-English read. What it is. Why a normal-looking gut can hurt anyway. An 8-item self-screen (not a diagnosis). How it is actually measured in research. What helps. And exactly when to push for a GI workup instead.
The short answer
Visceral hypersensitivity is a real, measurable nervous-system condition where the gut sends normal signals and the brain processes them as painful. Across rectal barostat studies, somewhere between 33 and 90 percent of IBS patients show measurable VH depending on the threshold used, with a figure near 60 percent commonly cited (Mertz 1995, Bouin 2002, Drossman Rome IV 2016). You cannot diagnose VH from an article, but the clinical pattern (pain-dominant symptoms, stress amplifies them, structural workup is clean, often coexists with conditions like fibromyalgia or interstitial cystitis) is recognizable. The 8-item self-screen below maps your situation against that pattern. If most of it fits, the next step is a basic GI workup to rule out structural disease and then a conversation about mechanism-targeted options (gut-directed hypnotherapy, gut-directed CBT, low-dose neuromodulators) rather than another round of diet changes that target anatomy your tests already said is fine.
Key takeaways
- Visceral hypersensitivity is real, measurable, and not 'in your head' in the dismissive sense: Same gut anatomy as healthy controls. Different nervous-system gain. Mertz 1995 and Bouin 2002 established this with rectal barostat. Aziz and Thompson 1998 mapped the three nodes where sensitization lives (peripheral nerves, spinal cord, central processing). Wilder-Smith 2004 fMRI localized the central node to anterior cingulate, insula, and prefrontal cortex. Drossman Rome IV (2016) places VH as a core mechanism in the multifactorial IBS model. Mayer 2011 (Nature Reviews Gastroenterology) gave the canonical gut-brain framework. The prevalence runs from 33 to 90 percent across IBS depending on the threshold used, with a midpoint near 60 percent.
- The 8-item self-screen is pattern-matching, not a diagnosis: There is no validated patient-facing screening questionnaire that maps directly onto barostat findings. What there is is a recognizable clinical phenotype: pain-dominant, stress-amplifying, clean structural workup, often comorbid with other central sensitization conditions, sometimes with a precipitating event in the history. The 8 items in section 3 are that phenotype translated to plain language. Five or more clearly fitting suggests the pattern; two or fewer suggests the dominant mechanism is probably somewhere else. Either way the next step is a conversation with your GI, not a self-treatment decision.
- What actually helps VH is mechanism-targeted, not symptom-targeted: Gut-directed hypnotherapy (70-75% response across trials, durable benefit). Gut-directed CBT (comparable efficacy where available). Low-dose neuromodulators under GI supervision (amitriptyline, nortriptyline 10-50 mg, duloxetine). MBSR (modest but durable). Dietary and anatomy-targeted interventions (low-FODMAP, peppermint oil, antispasmodics, fiber) address other layers of IBS that often coexist with VH but do not move the needle on nervous-system gain. Both layers can be addressed at the same time. Multiple rounds of restrictive diets without addressing the central gain often produces diminishing returns.
- Red flags override this entire article; the GI conversation is the gateway: Unintentional weight loss, blood in the stool, new onset after age 50, pain that consistently wakes you from sleep, persistent vomiting, difficulty swallowing, progressive worsening, abnormal labs, family history of colon cancer or IBD, or new severe pain departing from your baseline. Any of these means stop self-researching and seek medical evaluation. If none fit and your workup is reasonably complete, the next conversation with your GI uses the script in section 6 and is about treatment selection (mechanism-targeted options) rather than further diagnostic uncertainty.
Most people find this article one of two ways. Either they were listening to a podcast and the host mentioned that IBS is sometimes really 'visceral hypersensitivity' and the word stuck. Or they were on Reddit at 1am reading other people's IBS stories and someone in the comments said 'look up visceral hypersensitivity, that is probably what you have' and it landed. So now you are here, mechanism-curious, asking a fair question: is this me? Most of what is online about VH falls into one of three unhelpful categories. There are the academic papers, dense and not written for patients. There are the practitioner pages, which jump from 'this is a real thing' to 'book a consultation' too fast. And there are the AI-generated explainer pages that repeat the same six sentences with no real detail. This article is the read I would write for a friend who texted me 'I think this might be my whole problem, can you actually explain it and tell me how I would know if it is mine'. It is the biology in plain English, an honest 8-item self-screen (not a diagnosis), what the research actually measures, what actually helps, and exactly when to escalate to a GI workup. I am one option among several reasonable ones for the gut-directed hypnotherapy piece, but the goal here is for you to understand your own situation well enough to make a calibrated next move, not to sell you a session. If at the end of this you decide you want a session with me, fine. If you decide the basic GI workup is what you actually need first, that is the better outcome.
About 33 to 90 percent of IBS patients show visceral hypersensitivity on rectal distension testing. The range is wide because the threshold matters. The mechanism is real either way.
When you read that 'X percent of IBS patients have visceral hypersensitivity', the percentage you see depends entirely on where the researchers drew the line. Mertz 1995 (Gastroenterology, PMID 7797041) ran controlled rectal balloon distension on IBS patients and healthy controls and found that the IBS group reported pain at distension pressures the control group reported as merely full. Bouin 2002 (Gastroenterology, PMID 12055584) replicated and refined this. Across the broader literature, when you use a stricter threshold (the patient has to be more sensitive than 95 percent of controls), the prevalence comes in around 33 percent. When you use a looser threshold (any abnormal sensitivity counts), it can run as high as 90 percent. A figure near 60 percent is the midpoint commonly cited. The point is not to argue about the exact number. The point is that visceral hypersensitivity is a real, objectively measurable phenotype, not a complaint. The nervous-system gain has shifted. The gut wall has not. What this means for you: even on the strictest definition, a third of IBS patients have demonstrably altered nervous-system processing of gut signals. On looser definitions, the majority do. If your pain pattern fits the VH profile (you will know more after the self-screen in section 3), the mechanism story almost certainly applies to at least part of your picture. That does not mean VH is the only thing going on. Most IBS is multifactorial. But it does mean that interventions targeting the nervous-system gain are reasonable to consider, alongside whatever else your workup turns up.
What visceral hypersensitivity actually means (plain English, no jargon)
Start with the simplest possible version. Your gut moves food through it. As food moves, the gut wall stretches a little, contracts a little, registers pressure, registers temperature, registers chemistry. Sensory nerves in the gut wall pick all of this up and send signals up the spinal cord to the brain. The brain decides what to do with those signals. Most of the time, the brain decides 'this is fine, ignore it' and you do not consciously feel anything except maybe a vague awareness of digestion. Sometimes the brain decides 'this matters, pay attention' and you feel hunger, fullness, or the urge to use the bathroom. Occasionally the brain decides 'this is a problem' and you feel pain.
Visceral hypersensitivity is what happens when the 'this is a problem' threshold drops. The gut is sending the same signals it always was. The gut wall is anatomically normal on every test (colonoscopy, MRI, CT, biopsy, blood work). What has changed is that the brain is now interpreting normal-volume signals as painful. Imagine a smoke alarm that was set to go off at thick black smoke and is now set to go off when someone toasts bread. Nothing is wrong with the toast. Nothing is wrong with the smoke alarm itself. The sensitivity has been turned up.
Where the sensitivity actually lives. Aziz and Thompson 1998 (Gut, PMID 9824375) laid out the framework that still holds today. The pain signal travels through three nodes, and any of them can become sensitized. The first is the peripheral nerves in the gut wall themselves. Often these get sensitized after an episode of gastroenteritis (post-infectious IBS) or persistent inflammation. The second is the spinal cord, where the signal hops from one nerve to another. Repeated bombardment with pain signals can make this hop too easy, so even a weak signal coming up from the gut crosses the threshold to be sent on to the brain. The third is the brain itself, where the signal gets interpreted. Wilder-Smith 2004 (Gut, PMID 14724148) used functional MRI during rectal balloon distension and found that IBS patients with VH showed altered activation in three specific brain regions: the anterior cingulate cortex (which assigns emotional valence to sensations), the insula (which integrates body sensations into self-awareness), and the prefrontal cortex (which contextualizes them). The brain regions that interpret 'what does this feeling mean' are working differently in VH patients.
Why this is not 'in your head' in the dismissive sense. People hear 'the brain is interpreting normal signals as painful' and translate it to 'the doctor thinks I am imagining the pain'. That is not what the research shows. The pain is real. The nervous system is genuinely processing the signal as painful. What is not happening is structural damage in the gut. Both things are true at the same time. Mayer 2011 (Nature Reviews Gastroenterology, 'Gut feelings: the emerging biology of gut-brain communication') made the cleanest version of this argument: the gut and brain are bidirectionally connected through dense neural, hormonal, and immune pathways, and dysregulation in any of these pathways can produce real physical symptoms without producing visible structural pathology. Visceral hypersensitivity is one of the cleanest examples.
How this differs from the other things that can cause gut pain. If your gut wall is inflamed (Crohn's, ulcerative colitis, microscopic colitis), tests usually show it: elevated fecal calprotectin, abnormal biopsies, visible inflammation on imaging. If your gut is being mechanically obstructed (adhesions, strictures, severe constipation), tests usually show that too. If you have severe motility issues (gastroparesis, severe slow transit, dyssynergic defecation), specific testing can identify them. If your tests are clean and the pain is still real and your pain pattern fits the VH profile (next two sections), VH is one of the leading working hypotheses for what is going on. For a deeper dive on the hypnotherapy + VH evidence specifically, the 30-year synthesis article walks through the trial evidence in detail. This article stays on the biology and the self-screen.
Why it explains 'normal-looking' guts that hurt anyway (and why your GP did not explain this)
Here is the experience most VH patients have lived through. They go to the GP because something hurts. They get sent for tests. Tests come back clean. They get told some version of 'everything looks normal, it is probably IBS, manage your stress, watch your diet'. They go home no clearer than before. Pain continues. Eventually they find their way to an article like this one. The frustrating part is that the science behind 'normal-looking guts that hurt anyway' has been settled for decades. The translation from research to clinical conversation is what is broken.
Why your GP did not explain this. A few reasons, all real. First, GPs have eight to fifteen minutes per visit and explaining the gut-brain axis well takes longer than that. Second, most medical training emphasizes ruling out structural disease (the urgent stuff that can kill you) and treating it. The mechanism behind functional disorders gets a lot less curriculum time. Third, the field has been historically dismissive. For most of the twentieth century, 'IBS' was treated as a kind of code for 'I cannot find anything wrong with you and I think you are anxious'. The 1995 Mertz paper, which titled itself 'Altered rectal perception is a biological marker of patients with irritable bowel syndrome', was a deliberate intervention in this culture: the word 'biological marker' meant 'this is real, measurable, and not in the patient's imagination'. That message has not fully reached the front lines of primary care thirty years later.
Why your tests come back clean even though the pain is real. Because the tests are measuring the wrong layer. Endoscopy looks at the gut wall. Imaging looks at the structure. Biopsies look at tissue. None of these directly measure how the nervous system processes signals from the gut. The closest thing to a test for VH is rectal barostat (described in section 4), and it is essentially never ordered outside of research. So you can have severe, life-disrupting VH and a completely normal colonoscopy report. Both are true at the same time. The colonoscopy is doing exactly what it is designed to do (rule out cancer, inflammatory bowel disease, polyps, structural disease) and what it is not designed to do is detect altered nervous-system processing of gut signals.
The stress amplifier piece. Stress does not cause VH (mostly). What stress does is amplify it. The HPA axis (the hormonal stress response system) and the autonomic nervous system both directly affect gut motility and gut sensitivity. When you are stressed, the same baseline gut signal gets boosted on its way to the brain, and the brain is also in a more alarm-ready state, so it crosses the pain threshold faster. This is why VH symptoms classically flare during work stress, life transitions, anticipatory anxiety, and acute emotional events, and ease off during vacations and calm periods. Patients often misread this as 'the stress is causing my pain'. It is more accurate to say the stress is volume-knob on a pain that has its own underlying physiology. For a deeper read on the exact mechanism by which stress amplifies gut signals, does stress literally create gut pain walks through the HPA axis and vagal tone in detail.
Why 'just live with it' is not a satisfying answer (and not actually the medical position). A lot of patients come in having been told some version of 'you have IBS, nothing really fixes it, just manage it'. Drossman's Rome IV framework (Gastroenterology 2016, PMID 27144617), which is the current international diagnostic standard for functional GI disorders, explicitly lists multiple mechanism-targeted treatment options for IBS including gut-directed psychotherapy, low-dose neuromodulators, and dietary interventions. 'Just live with it' is not the Rome IV position. It is the busy-GP-with-no-time position. For a longer read on what to do when you have been told some version of this, what to do when your doctor says just live with IBS is the deep dive.
Why this matters for what you do next. If VH is part of your picture, the right interventions are nervous-system-targeted, not gut-anatomy-targeted. This is why VH patients sometimes do many rounds of dietary changes (low-FODMAP, gluten-free, dairy-free, low-histamine) with diminishing returns: they are addressing the wrong layer. Some dietary work can help (low-FODMAP genuinely helps a subset of IBS, particularly the distension-driven cases), but if your dominant mechanism is VH, expecting diet alone to fix it is like expecting a different toast to fix the smoke alarm sensitivity.
This is the cleanest imaging evidence that VH lives in the central processing of gut signals, not in the gut wall itself. The brain regions involved are the ones that assign emotional valence to sensations (anterior cingulate), integrate body sensations into self-awareness (insula), and contextualize them (prefrontal cortex). This is also why mechanism-targeted interventions like gut-directed hypnotherapy and gut-directed CBT work: they modulate exactly these regions.
Source: Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004; 53(11):1595-601. PMID 14724148.
Self-screen: 8 signs that suggest VH is part of your picture (this is NOT a diagnosis)
Read this section carefully because the framing matters as much as the content. What follows is a pattern-recognition tool. It is not a diagnostic instrument. There is no validated patient-facing screening questionnaire for visceral hypersensitivity that maps directly onto barostat findings. What there is, in the clinical literature, is a recognizable phenotype: the cluster of features that researchers describe when they talk about the VH-dominant IBS patient. The 8 items below are that phenotype, translated into plain language. Counting your 'yes' answers does not give you a diagnosis. It gives you a sense of how closely your pattern matches what the researchers describe.
How to use the 8 items. Read each one. Answer honestly. At the end, count how many fit. If five or more clearly fit, the VH phenotype is plausibly part of your picture. If two or fewer fit, your pain may be driven by something else (motility, dietary triggers, dysbiosis, mast cell activation, structural disease that has not been adequately worked up). Either way, the next step is a conversation with your GI, not a self-treatment decision. Section 6 covers the red flags that mean stop reading articles and call your doctor today.
Sign 1: Your pain is the dominant feature, not the bowel-habit changes. IBS classically presents with a combination of pain plus altered bowel habit (diarrhea, constipation, or both). VH-dominant IBS is the subtype where the pain is the loudest signal. You may have diarrhea or constipation too, but if someone asked you 'what is the worst part of your IBS', the answer is the pain, not the bathroom trips. This matters because pain is the symptom most closely tied to visceral sensitivity, while bowel-habit changes are more tied to motility.
Sign 2: Your tests are clean. You have had at least a basic GI workup (CBC, CRP, fecal calprotectin, celiac serology, often a colonoscopy if you are over 45 or have any red flags) and nothing showed up. The colon looks normal. Inflammation markers are normal. You are not anemic. Celiac antibodies are negative. The 'wrong' answer here is anything other than clean. If your workup turned up real findings, you may have a non-functional cause that needs addressing before assuming VH.
Sign 3: Stress reliably amplifies your symptoms. Not 'stress sometimes makes things worse'. More like 'I can map my flares to work stress, anticipated social events, relationship conflict, or sleep deprivation'. Vacations and calm periods reliably ease symptoms. The pattern is so consistent that you have started to dread stressful events partly because of what they do to your gut. This is the autonomic and HPA axis component of VH expressing itself.
Sign 4: You have at least one other condition that involves central sensitization. Fibromyalgia. Tension headaches or migraine. Chronic pelvic pain. Interstitial cystitis (painful bladder syndrome). Vulvodynia. Temporomandibular joint dysfunction (TMJ). Functional dyspepsia (upper-gut pain without structural cause). Chronic fatigue syndrome. The mechanism in all of these is similar: nervous-system processing of a body region has shifted toward registering pain at lower thresholds. The conditions cluster because the underlying biology is shared. If you have two or more of them, central sensitization is almost certainly part of your picture.
Sign 5: Eating amplifies pain even when the food is bland. Most IBS patients can identify trigger foods. VH-dominant patients often report that even bland, supposedly safe foods produce pain. The gut filling itself with anything (food, gas, water) becomes painful because the distension sensitivity has dropped. This is different from a clear food intolerance pattern (where specific foods reliably trigger and bland foods reliably do not). If you are puzzled by why 'safe' foods still hurt, distension hypersensitivity is a candidate.
Sign 6: Pain disrupts sleep or wakes you from sleep occasionally. Important caveat: pain that consistently wakes you from sleep is a red flag for structural disease and should be discussed with your GI directly (see section 6). But VH patients often report that pain disrupts sleep occasionally, especially during flares, and they often report waking with morning pain that eases as the day progresses. This is consistent with overnight gut motility producing distension that the sensitized system registers as painful.
Sign 7: You have a clear sense that your symptom severity has fluctuated over years rather than progressively worsened. VH and IBS are characteristically chronic-relapsing rather than progressively worsening. You have months where things are bad, months where things ease off, often without clear external cause. Progressive worsening (symptoms steadily getting worse over time) is a red flag for structural disease and warrants re-evaluation. Fluctuating chronicity is more consistent with the VH pattern.
Sign 8: You suspect your nervous system has been 'turned up' since a specific event. This could be a bad gastroenteritis episode (post-infectious IBS, a known precipitator of VH). A surgery on the gut or pelvis. A major emotional trauma. A period of severe stress. A long course of antibiotics with subsequent dysbiosis. Not every VH patient can identify a precipitating event, but a meaningful subset can, and the post-infectious subtype is particularly well-characterized in the research literature.
Counting your yeses. Five or more clear yeses, and the VH phenotype is plausibly part of your picture. The honest next step is sections 5 and 6: what actually helps, and when to escalate. Two or fewer yeses, and either your pain is driven by something else or your workup may not yet be complete. Either way, your next step is your GI, not your inbox. If you have been dismissed by a previous doctor and are not sure how to bring this up productively, what to do when your doctor says just live with IBS has the conversation framework.
How VH is actually diagnosed clinically (barostat protocols + why most GPs do not order this)
Worth being honest about the gap between how VH is identified in research and how it is identified in clinical practice in 2026. The research gold standard has existed for thirty years. The clinical practice has not caught up. Both facts are true.
The research standard: rectal barostat. A barostat is a pressure-controlled pump connected to a thin balloon mounted on a tube. The balloon is inserted into the rectum and inflated in controlled steps, either by pressure (millimeters of mercury) or volume (milliliters of air). At each step, the patient reports what they feel: nothing, fullness, urge, discomfort, pain. The pressure or volume at which the patient first reports pain is the pain threshold. Healthy controls typically report pain at around 40 to 50 mmHg in classic protocols (Mertz 1995, Bouin 2002). IBS patients with VH typically report pain at 15 to 30 mmHg, sometimes lower. Same anatomy, different threshold. This is the test that established VH as a real, measurable phenotype rather than a complaint.
Why most GPs do not order this. Three reasons, all practical. First, barostat equipment is research-only. Most GI departments do not own one, and the procedure is not a billable clinical service in most jurisdictions. Second, the test is somewhat invasive and uncomfortable, and ordering it on a patient who already meets clinical IBS criteria does not change the management plan in most cases (the GI will manage the patient based on symptoms regardless of the barostat result). Third, the test does not have a clean threshold that says 'you have VH, you do not have VH'. It is a continuous measure across a population, and individual results have to be interpreted in context. So in practice, even the GIs who could in principle order a barostat usually do not.
What clinicians actually do instead. They use the clinical pattern. Drossman's Rome IV criteria (Gastroenterology 2016, PMID 27144617) define IBS based on the recurrent abdominal pain pattern (at least one day per week in the last three months, related to defecation or change in bowel habit). Within IBS, the VH-dominant phenotype is inferred from the cluster you saw in section 3: pain-dominant, stress-amplifying, clean structural workup, often comorbid with other central sensitization syndromes. This is a clinical inference, not a measurement. It is good enough to guide treatment selection but not as definitive as a positive barostat result would be.
What a thorough GI workup actually includes for someone in your situation. This is what you should expect or ask for, not what every GP does by default. CBC and CRP to rule out anemia and inflammation. Fecal calprotectin to rule out inflammatory bowel disease. Celiac serology (tissue transglutaminase IgA, total IgA). TSH for thyroid involvement. Stool studies for infection if there are diarrhea-dominant features. Colonoscopy if you are 45+ in Canada, or have any red flag features, or have a family history of colon cancer or IBD. Sometimes a SeHCAT scan or empirical trial of cholestyramine if bile acid malabsorption is suspected. Imaging (CT, MR enterography) if there is suspicion of small-bowel disease. Hydrogen breath testing if SIBO is suspected. The standard workup is meant to rule out structural and metabolic disease so that what remains (the functional disorder with VH features) can be addressed with mechanism-targeted treatment.
Why barostat does not need to be done on you. Because it would not change management in practice. If your pattern matches VH and your structural workup is clean, the treatment options that target VH (gut-directed hypnotherapy, gut-directed CBT, low-dose tricyclics or SNRIs under GI supervision, mindfulness-based stress reduction) are the same options whether or not you have a documented barostat threshold of 22 mmHg or 28 mmHg. The barostat would confirm what the clinical pattern already implies. So in practice, the clinical pattern is doing the work the test would do.
What this means if you are still confused after this section. Confusion at this point usually means one of two things. Either your basic workup is not yet complete (and that needs to happen before assuming functional disorder), or your workup is complete and your pattern fits VH and the next conversation is about what to actually do. Sections 5 and 6 cover both.
Same anatomy. Same rectum. Same balloon. Different nervous-system gain. Barostat is essentially never ordered in clinical practice because the equipment is research-only and the test does not change management (treatment selection follows the clinical pattern, not the barostat number). Your GI will infer VH from your symptom pattern, not from a test.
Source: Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109(1):40-52. PMID 7797041. Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122(7):1771-7. PMID 12055584.
What ACTUALLY helps VH (mechanism-targeted options that change the gain, not just the diet)
If the problem is nervous-system gain, the interventions that work are the ones that target nervous-system gain. The interventions that target gut anatomy or dietary triggers can still help (most IBS is multifactorial and there is usually more than one mechanism involved) but they are addressing a different layer. The list below is the mechanism-targeted layer.
Option 1: Gut-directed hypnotherapy (GDH). This is the most-studied mechanism-targeted intervention for VH. The two standardized protocols with the most published evidence are the Manchester Protocol (Peter Whorwell's group, University of Manchester) and the North Carolina Protocol (Olafur Palsson and William Whitehead, University of North Carolina). Across the major trials, response rates cluster at 70 to 75 percent (Whorwell long-term audit, Peters 2016, Moser 2013), with unusually durable benefit (the Whorwell audit showed about 70 percent of responders maintaining benefit at 1 to 5 years post-treatment). The mechanism-level evidence is also unusually strong: Lea 2003 (Aliment Pharmacol Ther) and Houghton 2000 (Gut) showed that responders normalize their rectal distension pain thresholds on barostat, not just their symptom scores. For the deep dive on the GDH + VH literature, the 30-year synthesis article walks through every major trial. For the broader evidence on gut-directed therapies including how GDH stacks up against everything else, the flagship hub article is the orientation read.
Option 2: Gut-directed cognitive behavioral therapy (CBT). Lackner and colleagues (Gastroenterology 2018) and Everitt and colleagues (Gut 2019, the ACTIB trial) have the largest evidence base for gut-directed CBT. The mechanism is different from GDH (CBT targets the cognitive and behavioral mediators of central pain processing; GDH targets the central state directly through focused attention and gut-specific imagery) but the target is the same: reduce nervous-system amplification of gut signals. Response rates are broadly comparable, durability is also good. Access in Canada is uneven; most psychologists who deliver CBT do not have specific training in the gut-directed variant. If you can find one (the academic centers in Toronto, Montreal, and Vancouver are the most likely places), it is a strong option.
Option 3: Low-dose neuromodulators under GI supervision. Tricyclic antidepressants (amitriptyline, nortriptyline) at doses far below antidepressant doses (typically 10 to 50 mg at night) directly modulate descending pain pathways and reduce visceral hypersensitivity. SNRIs (duloxetine) can play a similar role. The American College of Gastroenterology IBS guidelines (2021) include low-dose tricyclics as a reasonable option for pain-predominant IBS that has not responded to first-line measures. These are prescription medications and require GI or family physician supervision. Side effects (dry mouth, drowsiness, weight changes, constipation, sexual side effects) are real even at low doses and limit some patients. Worth a conversation with your GI.
Option 4: Mindfulness-based stress reduction (MBSR). Kabat-Zinn's original 8-week MBSR programs, and adaptations for IBS specifically (Gaylord and colleagues, Am J Gastroenterol 2011), produce modest benefit in IBS symptom scores. The mechanism is partly central (sustained attention training appears to modulate central pain processing) and partly autonomic (slow breathing increases vagal tone). The effect size is smaller than GDH or CBT but the access is much better (MBSR programs are widely available, often through hospitals or community programs at modest cost) and the program teaches durable skills.
Option 5: Low-dose neuromodulator-adjacent options used by some patients. Some patients use over-the-counter options like L-theanine, magnesium glycinate, or melatonin (for the gut-motility effect, not for sleep) and report benefit. Evidence base is weak. Mention is for completeness, not endorsement.
What helps less than people hope, when VH is the dominant mechanism. Round after round of restrictive diets. Low-FODMAP can help (Peters 2016 showed it performed comparably to GDH in head-to-head comparison), but the effect plateaus and the diet is not sustainable long-term. For the deeper dive on the FODMAP-vs-GDH comparison, the Peters 2016 breakdown is the read. Probiotics: weak evidence overall, particular strains may help particular patients but no general recommendation holds up. Peppermint oil: helps with cramping (local smooth-muscle effect) but does not address central sensitization. Antispasmodics: similar story. Fiber: helps constipation-predominant IBS but is roughly neutral or slightly worsening for pain-predominant IBS. None of these are useless. They just are not targeting the layer that matters most for VH.
The honest framing on cost and access. Gut-directed hypnotherapy in Canada is typically $220 to $350 per session for clinicians credentialed by the Association of Registered Clinical Hypnotherapists of Canada (ARCH-Canada), which is Canada's most stringent voluntary professional body for clinical hypnotherapy. Course length is 7 to 12 sessions. A starter package of 3 sessions ($660 to $1,050) lets both parties evaluate fit. Hypnotherapy is not directly covered by Canadian provincial health plans or most extended health benefit plans. Hypnotherapy is not a regulated profession in Alberta. Some clients get reimbursement through their employer's Wellness Spending Account (WSA) under categories like 'stress management' or 'mental wellness'. WSAs are different from Health Spending Accounts (HSAs), which follow strict CRA medical-expense rules that exclude practitioners who are not on a provincial regulated list. Always check with your specific plan whether RCH services qualify. Gut-directed CBT, when delivered by a registered psychologist, may be covered under extended health benefits. Low-dose neuromodulators are inexpensive generics covered by most drug plans. MBSR program costs vary widely.
When to escalate to GI workup (red flags + what to ask your doctor)
Most people reading this article are not in a medical emergency. They are in a chronic-low-grade-confusion situation. But some features should override the article and send you back to medical attention, sometimes urgently. This section is the override list and the script for what to ask.
Red flag 1: Unintentional weight loss. More than about 5 percent of your body weight lost over the past 6 to 12 months without trying. This is significant and should be evaluated, particularly if accompanied by any of the other red flags. Weight loss is uncommon in functional GI disorders and common in structural and inflammatory ones.
Red flag 2: Blood in the stool. Any blood. Bright red, dark, or melena (black, tarry, sticky stool). Hemorrhoids and anal fissures can produce blood that is bright red and on the surface; that has a known cause but still warrants confirmation. Blood mixed into the stool, or any darker blood, warrants prompt GI evaluation.
Red flag 3: New onset of significant symptoms after age 50. IBS typically begins in the teens, twenties, or thirties. New onset in someone over 50 is more likely to reflect a structural cause and warrants colonoscopy plus a broader workup before assuming IBS.
Red flag 4: Pain that consistently wakes you from sleep. Occasional sleep disruption from pain is common in IBS. Pain that consistently and reliably wakes you, night after night, is more characteristic of inflammatory or structural disease and warrants evaluation.
Red flag 5: Persistent vomiting, difficulty swallowing, or progressive symptoms. Functional GI disorders usually fluctuate. Progressive worsening, persistent vomiting (not occasional), or new difficulty swallowing all point toward structural causes and need evaluation.
Red flag 6: Anemia or other lab abnormalities. If your CBC shows iron-deficiency anemia, if your CRP is elevated, if your fecal calprotectin is elevated, if your celiac serology is positive, the workup is not done. These are findings, not just numbers, and they warrant follow-up.
Red flag 7: Family history of colon cancer, IBD, or celiac disease (especially first-degree relatives). This shifts the threshold for colonoscopy and broader workup downward. If you are in your thirties with concerning symptoms and a first-degree relative with colon cancer or IBD, your workup should be more aggressive than if you have no family history.
Red flag 8: New severe pain, or a clear escalation of pain pattern that does not match your usual baseline. Functional disorders fluctuate but usually within a recognizable envelope. A sudden severe departure from your baseline, especially with associated fever or signs of obstruction, warrants urgent evaluation.
What to ask your doctor if you have read this article and you suspect VH. A short script. 'I have been reading about visceral hypersensitivity as a mechanism in IBS. My pattern matches a lot of what is described: pain is the dominant symptom, stress amplifies it, my workup so far has been clean. I would like to confirm my workup is complete enough to be confident this is functional rather than structural, and I would like to discuss treatment options that target the visceral hypersensitivity mechanism specifically, like gut-directed hypnotherapy, gut-directed CBT, or low-dose neuromodulators. What would you recommend as the next step?' This script does three things at once. It signals you have read the literature, which usually shifts the conversation toward a more collaborative register. It explicitly asks about workup completeness rather than assuming. And it names the specific intervention categories rather than asking the GI to come up with the list. For a more thorough script specifically for the GI conversation including what to do if the GI is unfamiliar with gut-directed hypnotherapy, how to talk to my GI about hypnotherapy is the deep dive.
The honest summary on escalation. If any red flag fits, do not self-treat with anything based on this article. Get the medical evaluation first. If no red flag fits and your workup is reasonably complete, the conversation with your GI is about treatment selection, not further diagnostic uncertainty. Either path is reasonable. The wrong path is reading articles like this one indefinitely without actually returning to medical care to close the loop.
| What you might try | What it targets | How well it helps VH-dominant pain | Honest limit |
|---|---|---|---|
| Gut-directed hypnotherapy (Manchester or North Carolina Protocol) | Central nervous-system gain on visceral signals | Strong: 70-75% response across trials, durable | Practitioner quality varies; field is unregulated in Canada |
| Gut-directed CBT (Lackner 2018, Everitt ACTIB 2019) | Cognitive and behavioral mediators of central pain | Strong: comparable to GDH where available | Access in Canada is uneven; few therapists trained in gut-directed variant |
| Low-dose tricyclics (amitriptyline, nortriptyline 10-50mg) | Descending pain pathways and visceral sensitivity | Moderate to strong for pain-predominant IBS | Side effects (dry mouth, drowsiness, weight) limit some patients |
| SNRIs at lower doses (duloxetine) | Similar to tricyclics, descending pain modulation | Moderate, less evidence than tricyclics in IBS specifically | Same side effect profile considerations; requires GI supervision |
| Mindfulness-based stress reduction (MBSR) | Central pain processing + autonomic regulation | Modest but durable; access is good | Effect size smaller than GDH or CBT; requires 8 weeks commitment |
| Low-FODMAP diet (Peters 2016) | Fermentable carbohydrate triggers + distension load | Helpful (comparable to GDH in Peters head-to-head) but plateaus | Restrictive, not sustainable long-term, does not address central gain |
| Peppermint oil | Local smooth-muscle relaxation | Helps cramping; does not address VH directly | Heartburn for some; targets a different layer than VH |
| Antispasmodics (hyoscine, dicyclomine) | Smooth muscle | Helps cramps during flares | Symptomatic only; no mechanism effect on VH |
| Probiotics (general) | Microbiome modulation | Weak overall; specific strains may help specific patients | Effect highly variable; no general recommendation |
| Fiber supplementation (psyllium) | Stool bulk and motility | Helps constipation-predominant IBS | Roughly neutral or worsening for pain-predominant VH |
| Elimination diets beyond low-FODMAP | Suspected immune or histamine triggers | Mixed; helps subsets but commonly over-applied | Restrictive, can drive disordered eating, often diminishing returns |
If you are trying to figure out whether your pattern actually matches the VH phenotype that the research describes, the 8-item self-screen in section 3 is the structured version of that comparison. It is not a diagnosis. It is a pattern-matching exercise. If five or more of the items clearly fit, the VH phenotype is plausibly part of your picture and the conversation with your GI shifts toward treatment selection. If two or fewer fit, your dominant mechanism is probably somewhere else and the workup conversation is what comes first.
2-Minute Self-Check
How hypnotizable are you?
Most people have no idea. Six quick questions will show you where you land.
6 questions · based on the Stanford & Tellegen clinical scales
Questions this page answers
Can I diagnose myself with visceral hypersensitivity from this article?
No. The self-screen in section 3 is a pattern-recognition tool, not a diagnostic instrument. There is no validated patient-facing screening questionnaire for VH that maps directly onto barostat findings. What the self-screen can do is help you decide whether the VH pattern plausibly fits your situation, which is a reasonable input to a conversation with your GI but not a substitute for one.
Is visceral hypersensitivity the same as IBS?
Not exactly. IBS is a clinical syndrome defined by recurrent abdominal pain plus altered bowel habit. Visceral hypersensitivity is one of the underlying mechanisms that contributes to IBS in a meaningful subset of patients. Across the literature, the percentage of IBS patients who show measurable VH on rectal distension testing runs from about 33 percent on stricter thresholds to about 90 percent on broader ones, with a midpoint near 60 percent commonly cited. So VH is common in IBS but not universal, and IBS is the clinical label while VH is one of the mechanisms underneath it.
Why does the percentage of IBS patients with VH vary so widely across studies (33 to 90 percent)?
Because where you draw the threshold matters. Mertz 1995 and Bouin 2002 used rectal balloon distension and measured pain thresholds on a continuous scale. There is no clean line that says 'above this pressure you have VH, below this you do not'. Different studies have used different cutoffs and different methodologies, producing different prevalence figures. The wider point is that VH is real, objectively measurable, and present in a substantial fraction of IBS patients regardless of where you draw the line.
Will my GI order a barostat to confirm VH?
Almost certainly not. Barostat is research-only in most clinical settings in 2026. Most GI departments do not have the equipment, and the procedure does not change management in practice because treatment selection follows the clinical pattern rather than the test result. Your GI will infer VH from the clinical pattern (pain-dominant IBS, stress-amplifying, clean workup, often comorbid with other central sensitization conditions) the same way researchers describe the VH phenotype.
Is stress causing my visceral hypersensitivity?
Mostly not. Stress amplifies VH but does not usually cause it. The underlying physiology (altered nervous-system processing of gut signals) has its own origin, often a post-infectious event, sometimes a slow accumulation through repeated insults. Stress functions as the volume knob: it makes existing VH worse during stressful periods and lets it ease during calm ones. Treating only the stress without addressing the underlying gain rarely produces durable change.
What is the difference between visceral hypersensitivity and central sensitization?
Closely related but slightly different scopes. Visceral hypersensitivity is specifically about altered processing of signals from internal organs (mostly gut and pelvis). Central sensitization is the broader phenomenon of altered processing of signals from any part of the body, of which VH is one regional expression. Patients with VH frequently have central sensitization features elsewhere (fibromyalgia, chronic pelvic pain, interstitial cystitis, tension headaches) because the underlying biology is shared.
I had post-infectious IBS after gastroenteritis. Is that the same as visceral hypersensitivity?
Post-infectious IBS is one of the best-characterized routes into VH. After a gastroenteritis episode, peripheral sensitization of gut nerve endings can persist long after the infection clears, and through repeated signaling can eventually drive central sensitization. So post-infectious IBS frequently has VH as a major component. Not every post-infectious IBS patient ends up with full VH, but the overlap is substantial.
How much does gut-directed hypnotherapy cost in Canada and is it covered by insurance?
ARCH-credentialed clinicians in Canada typically charge $220 to $350 per session, with a course of 7 to 12 sessions. A starter package of 3 sessions ($660 to $1,050) lets both parties evaluate fit. Hypnotherapy is not directly covered by Canadian provincial health plans or most extended health benefit plans. Hypnotherapy is not a regulated profession in Alberta. Some clients get reimbursement through their employer's Wellness Spending Account (WSA) under categories like 'stress management' or 'mental wellness'. WSAs are different from Health Spending Accounts (HSAs), which follow strict CRA medical-expense rules that exclude practitioners who are not on a provincial regulated list. Always check with your specific plan whether RCH services qualify.
What if my self-screen comes back with only one or two yeses?
Then the VH phenotype probably is not the dominant mechanism in your case. Your pain may be driven by motility (more bowel-habit dominant), dietary triggers (clearer trigger-food pattern), microbial factors (sometimes with bloating-dominant presentation), mast cell activation (with allergic features), or structural disease that has not been adequately worked up. The next step in that case is the GI workup conversation, not a treatment decision based on this article.
Should I try gut-directed hypnotherapy before low-dose tricyclics or after?
There is no single right order, and reasonable clinicians disagree. The ACG IBS guidelines (2021) treat both as reasonable options for pain-predominant IBS after first-line measures. Some patients prefer hypnotherapy as a first step because it does not involve medication and the durability data are unusually good. Others prefer low-dose tricyclics as a first step because they are inexpensive, available through the family physician, and produce measurable effect faster. Some try both in sequence if one stalls. The honest answer is that it is a conversation between you and your GI about your preferences, your prior treatment history, and your comorbidities.
I have read this whole article and I am still not sure whether VH applies to me. What now?
Then you have done the right thing by reading it carefully. The next step is to print the self-screen in section 3 plus the comparison table in section 5, take both to your GI, and have the conversation. Your GI is in a far better position to integrate your clinical history with this framework than you are alone. The article is a preparation tool for that conversation, not a substitute for it.
Does gut-directed hypnotherapy work for everyone with VH?
No. Across the major trials, the response rate is 70 to 75 percent, which is high for IBS interventions but also means 25 to 30 percent of patients do not respond meaningfully. Reasons for non-response are not fully understood. Possibilities include consolidated central sensitization, comorbid central pain syndromes, ongoing severe stress, mismatch between the patient's cognitive style and the hypnotic intervention, or co-occurring drivers that overwhelm the mechanism. Calibrated expectations matter more than enthusiastic ones.
I am Danny M., a Registered Clinical Hypnotherapist (RCH) at Calgary Gut Hypnotherapy. If you read this article because you encountered the phrase 'visceral hypersensitivity' somewhere and wanted to know whether it actually applies to you, that is the audience this was written for. The honest summary is that VH is real, measurable, and present in a substantial fraction of IBS patients regardless of where you draw the line. You cannot diagnose it from an article, but the clinical pattern is recognizable, and the 8-item self-screen in section 3 is a structured way to compare your situation against what the research describes. The mechanism-targeted interventions that help VH include gut-directed hypnotherapy, gut-directed CBT, low-dose neuromodulators under GI supervision, and MBSR. Calgary Gut Hypnotherapy is one option among several reasonable ones for the GDH piece. Sessions are $220 to $350 per session depending on complexity, with a 3-session commitment ($660 to $1,050) so you can evaluate fit before committing to a longer course. Capped at 10 new clients per month, virtual across Canada or in person in Calgary. If your basic medical workup is clean and your pattern fits the VH profile, a free consultation is a reasonable next step. If your workup is not complete or any red flag in section 6 fits, the GI conversation comes first. If you read this and decide to work with a different ARCH-credentialed practitioner, or with a clinician using the North Carolina Protocol through a different practice, or with a registered psychologist trained in gut-directed CBT, all of those are good outcomes. The work is for you to make a calibrated next move.
Apply to work with us
We take on just 10 new clients a month. Apply below for an honest answer on whether hypnotherapy is the right fit — no packages, no pressure.
Only 2 spots left for May
About the Author

Danny M., Registered Clinical Hypnotherapist (RCH)
Danny is a Registered Clinical Hypnotherapist (RCH) with the Association of Registered Clinical Hypnotherapists of Canada (ARCH-Canada). At Calgary Gut Hypnotherapy he focuses on gut-directed hypnotherapy for IBS, SIBO, functional dyspepsia, and the gut-brain conditions hypnotherapy has the strongest track record with. Sessions run $220 to $350 each, structured around a 3-session commitment rather than open-ended therapy. Delivered fully online with clients across Canada and in-person in Calgary.
Learn more about our approachImportant: Hypnotherapy is a guided focused-attention practice, not medical care, not psychotherapy, and not a psychological treatment. Hypnotherapy is not a regulated health profession in any Canadian province, including Alberta. ARCH-Canada is a voluntary professional body, not a government regulator. Nothing on this site is medical advice, diagnosis, or treatment. Always consult your physician, gastroenterologist, or other licensed health professional for diagnosis, medication decisions, red-flag symptoms, or any medical concern. Hypnotherapy may complement medical care but never replaces it.